Does LEDIPASVIR\SOFOSBUVIR Cause Mobility decreased? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Mobility decreased have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 0.1% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.
21
Reports of Mobility decreased with LEDIPASVIR\SOFOSBUVIR
0.1%
of all LEDIPASVIR\SOFOSBUVIR reports
1
Deaths
6
Hospitalizations
How Dangerous Is Mobility decreased From LEDIPASVIR\SOFOSBUVIR?
Of the 21 reports, 1 (4.8%) resulted in death, 6 (28.6%) required hospitalization, and 1 (4.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?
Fatigue (4,609)
Headache (4,203)
Nausea (1,471)
Drug ineffective (1,397)
Hepatitis c (1,076)
Diarrhoea (1,065)
Insomnia (1,021)
Hepatocellular carcinoma (640)
Vomiting (623)
Dizziness (604)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Mobility decreased Risk?
LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE
LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT
LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR
LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE
LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB